Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline OTEX Q1 2026 Earnings EPS Surpasses Estimates by 75 Stock Declines TTI Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Movement LAMR Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response CZFS Q1 2026 Earnings EPS Beats Estimates by 695 as Solid Core Performance Offsets Market Uncertainty GEG Q1 2026 Earnings Significant Earnings Miss Despite No Revenue Impact